Home » Topics » Conferences

Conferences
RSS

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Effects of rPAF-AH in opossums with severe pancreatitis

Nov. 20, 1997

Thalidomide proves effective in HIV-associated proctitis

Nov. 20, 1997

L-Arginine safe and effective in spastic esophageal motor disorders

Nov. 19, 1997

New laxative proves safe and effective for short-term treatment of constipation

Nov. 19, 1997

Centocor's anti-TNF-alpha antibody closes fistulae in Crohn's patients

Nov. 19, 1997

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

New cardiotonic agent reported by Japanese academics

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.